Published in Naunyn Schmiedebergs Arch Pharmacol on July 01, 1988
Effects of N-ethylmaleimide on 5-hydroxytryptamine transport and sodium content in rabbit platelets. Br J Pharmacol (1989) 0.78
Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers. Eur J Clin Microbiol (1984) 3.58
[Enzyme induction by drugs and hormonal contraception]. Zentralbl Gynakol (1973) 1.48
Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. Br J Pharmacol (2002) 1.40
Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol (1995) 1.25
The structure of a trimeric archaeal adenylate kinase. J Mol Biol (1998) 1.18
Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet (1996) 1.09
Extraneuronal removal, accumulation and O-methylation of isoprenaline in the perfused heart. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.04
Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells. Naunyn Schmiedebergs Arch Pharmacol (1993) 1.03
Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity. J Biol Chem (2000) 1.01
Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine, and nimodipine. Am J Nephrol (1986) 1.00
The effect of new alpha-glucosidase inhibitors (BAY m 1099 and BAY o 1248) on meal-stimulated increases in glucose and insulin levels in man. Klin Wochenschr (1986) 0.99
Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.99
Analysis of the compartments involved in the extraneuronal storage and metabolism of isoprenaline in the perfused heart. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.97
Thermodynamics and kinetics of unfolding of the thermostable trimeric adenylate kinase from the archaeon Sulfolobus acidocaldarius. J Mol Biol (1998) 0.97
Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1/SLC22A1). Ann Hum Genet (1999) 0.97
Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.96
Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen. Intervirology (1996) 0.95
Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.94
Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo. Eur J Immunol (1994) 0.93
Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors. Neurochem Int (2002) 0.92
Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex. Eur J Pharmacol (1990) 0.92
The effect of hydrocortisone on the sensitivity of the isolated nictitating membrane to catecholamines: Relationship to extraneuronal uptake and metabolism. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.92
Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.91
Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J Immunol (1995) 0.91
Neuronal and extraneuronal uptake and metabolism of catecholamines. Gen Pharmacol (1983) 0.90
5-HT3 receptors in outside-out patches of N1E-115 neuroblastoma cells: basic properties and effects of pentobarbital. Neuropharmacology (1997) 0.90
Effects of monovalent ions on the transport of noradrenaline across the plasma membrane of neuronal cells (PC-12 cells). J Neurochem (1985) 0.89
Cloning and functional characterization of the human norepinephrine transporter gene promoter. J Neural Transm (Vienna) (1998) 0.89
Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH. Neurosci Lett (1998) 0.89
Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter. Hum Genet (1993) 0.89
Inhibition of 5-HT3 receptors by propofol: equilibrium and kinetic measurements. Neuropharmacology (2000) 0.88
[Peritoneal dialysis in the treatment of thyroid crisis]. Dtsch Med Wochenschr (1971) 0.88
Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem Biophys Res Commun (1995) 0.88
Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters. J Pharmacol Exp Ther (1999) 0.87
Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J Biol Chem (1995) 0.87
Laparoscopic management of ovarian tumors. Surg Endosc (1998) 0.87
Learning and memory in 5-HT(1A)-receptor mutant mice. Behav Brain Res (2008) 0.87
The transport of (+)-amphetamine by the neuronal noradrenaline carrier. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.87
Binding of 3H-desipramine to the neuronal noradrenaline carrier of rat phaeochromocytoma cells (PC-12 cells). Naunyn Schmiedebergs Arch Pharmacol (1986) 0.87
Cloning and expression of the bovine sodium- and chloride-dependent noradrenaline transporter. FEBS Lett (1994) 0.86
Kinetic analysis of the interaction between noradrenaline and Na+ in neuronal uptake: kinetic evidence for CO-transport. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.86
Modified 5-HT3A receptor function by co-expression of alternatively spliced human 5-HT3A receptor isoforms. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.86
Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.85
The neuronal noradrenaline transport system of PC-12 cells: kinetic analysis of the interaction between noradrenaline, Na+ and Cl- in transport. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.85
Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors. J Neurochem (2006) 0.85
Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders. Neurogastroenterol Motil (2014) 0.84
Pharmacological properties of naturally occurring variants of the human norepinephrine transporter. Pharmacogenetics (2000) 0.84
Further studies on the extraneuronal uptake and metabolism of isoprenaline in the perfused rat heart. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.84
Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.84
A variant of the bovine noradrenaline transporter reveals the importance of the C-terminal region for correct targeting to the membrane and functional expression. Biochem J (1998) 0.84
The rat norepinephrine transporter: molecular cloning from PC12 cells and functional expression. Brain Res Mol Brain Res (1997) 0.84
The human noradrenaline transporter gene contains multiple polyadenylation sites and two alternatively spliced C-terminal exons. Biochim Biophys Acta (1998) 0.84
Presynaptic imidazoline receptors. New developments in characterization and classification. Ann N Y Acad Sci (1999) 0.84
Stress protein (hsp73)-mediated, TAP-independent processing of endogenous, truncated SV40 large T antigen for Db-restricted peptide presentation. Eur J Immunol (1997) 0.84
Axilloscopy and endoscopic sentinel node detection in breast cancer patients. Surg Endosc (2000) 0.84
MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr (1997) 0.84
Tourette syndrome and the norepinephrine transporter gene: results of a systematic mutation screening. Am J Med Genet (1999) 0.83
SiMa, a new neuroblastoma cell line combining poor prognostic cytogenetic markers with high adrenergic differentiation. Cancer Genet Cytogenet (1999) 0.83
The prejunctional effect of cocaine on the isolated nictitating membrane of the cat. Naunyn Schmiedebergs Arch Pharmacol (1972) 0.83
Role of nitric oxide formation in the regulation of haemodynamics and the release of noradrenaline and adrenaline. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.83
Genetic variation in human 5-HT receptors: potential pathogenetic and pharmacological role. Ann N Y Acad Sci (1998) 0.83
The influence of block and catechol-O-methyl transferase on the sensitivity of isolated organs to catecholamines. Naunyn Schmiedebergs Arch Pharmakol (1971) 0.83
Pharmacokinetic and alpha 1-adrenoceptor antagonistic properties of two cyanine-type inhibitors of extraneuronal monoamine transport. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.83
Species-specific pharmacological properties of human alpha(2A)-adrenoceptors. Hypertension (2000) 0.82
Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.82
The O-methylation of extraneuronally stored isoprenaline in the perfused heart. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.82
DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors. J Immunol (1996) 0.82
Inhibition of 5-HT3 receptor cation channels by ifenprodil in excised patches of N1E-115 cells. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.82
[Cervix pregnancy following abortion]. Zentralbl Gynakol (1974) 0.82
The rate constants for the efflux of metabolites of catecholamines and phenethylamines. Pharmacol Rev (1979) 0.81
Structure of the human histamine H3 receptor gene (HRH3) and identification of naturally occurring variations. J Neural Transm (Vienna) (2002) 0.81
The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.81
Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1. Arzneimittelforschung (1985) 0.81
Three extremely thermostable proteins from Sulfolobus and a reappraisal of the 'traffic rules'. Biol Chem (1997) 0.81
Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast. Br J Cancer (1999) 0.81
Kinetics of the uptake and metabolism of 3H-(+/-) isoprenaline in the rat submaxillary gland. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.81
Analysis of the gene structure of the human (SLC22A3) and murine (Slc22a3) extraneuronal monoamine transporter. J Neural Transm (Vienna) (2000) 0.80
Inhibition of neuronal noradrenaline uptake (uptake1) and desipramine binding by N-ethylmaleimide (NEM). Naunyn Schmiedebergs Arch Pharmacol (1988) 0.80
Temperature sensitivity of the extraneuronal uptake and metabolism of isoprenaline in the perfused rate heart. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.80
Molecular cloning and functional expression of the mouse dopamine transporter. J Neural Transm (Vienna) (1999) 0.80
Supersensitivity to catecholamines after impairment of extraneuronal uptake or catechol-O-methyl transferase. Fed Proc (1975) 0.80
Agmatine and putrescine uptake in the human glioma cell line SK-MG-1. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.80
The rate constants for the efflux of the metabolites of noradrenaline from rabbit aortic strips. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.80
Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.80
[Epidermal reaction following effect of urea. II. Biometric results]. Dermatol Monatsschr (1974) 0.79
The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.79
Stereoselectivity in the metabolism of 3H-noradrenaline during uptake into and efflux from the isolated rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.79
The effect of various ions on uptake2 of catecholamines. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.79
Relationship between the uptake of 3H-(+/-)metaraminol and the density of adrenergic innervation in isolated rat tissues. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.79
[Laurence-Moon-Bardet-Biedl syndrome and endometrial carcinoma]. Zentralbl Gynakol (1978) 0.79
Saturation kinetics of the adrenergic neurone uptake system in the perfused rabbit heart. A new method for determination of initial rates of amine uptake. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.79
Extraneuronal transport of catecholamines. Pharmacology (1980) 0.79
[Epidermal reaction following effect of urea. I. Epidermal test system]. Dermatol Monatsschr (1974) 0.79
Uptake of 14C-tyramine and release of extravesicular 3H-noradrenaline in isolated perfused rabbit hearts. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.79
Sympathomimetic effects of MIBG: comparison with tyramine. J Nucl Med (1999) 0.79
Synthesis and characterization of fluorescent ligands for the norepinephrine transporter: potential neuroblastoma imaging agents. J Med Chem (1999) 0.79
Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes. Biol Chem Hoppe Seyler (1994) 0.79